ABSTRACT Bronchial hyper-responsiveness is a particular feature of asthma, but also occurs in normal subjects after a viral upper the second by saline as placebo. The study was performed double-blind and in random order. After pretreatment with PGF2ot the histamine dose-response curve was significantly shifted to the left in a parallel fashion (p < 0-001). There was a significant decrease in the doses of histamine required to cause a 20 fall in sGaw (p < 00015) but no significant change in the slopes of the dose-response regression lines, indicating that bronchial muscle sensitivity rather than reactivity had been predominantly affected.
Increased responsiveness of bronchial smooth muscle to a wide variety of pharmacological and nonspecific stimuli is one of the most characteristic yet poorly understood features of bronchial asthma.' 2 It also occurs in normal subjects shortly after a viral upper respiratory tract infection,3 influenza vaccination,45 or ozone inhalation,6 and is exaggerated in atopic subjects exposed to allergen in doses insufficient in themselves to affect airways calibre. 7 Although the participation of cholinergic reflexes is well recognised in the expression of bronchial hyper-responsiveness,3 a solely neurological mechanism could not account for all its features.8 One explanation could be that biochemical mediators of the inflammatory response might potentiate the response to reflex cholinergic stimulation. Prostaglandins (PGs) have been shown to modify responses to a variety of neurotransmitters9 10 and hormones," and PGF2a potentiates the contractile response of both guinea-pig'2 13 and human14 respiratory smooth muscle to a variety of bronchoconstrictor mediators.
The object of this study was to explore the possibility that PGF2a in vivo in concentrations too low to influence bronchial muscle tone might increase the responsiveness of the airways to pharmacological stimuli. A preliminary study (Dunlop LS, personal communication) has suggested that this might be the case.
Methods
Nine normal, non-asthmatic, non-atopic adult volunteers (three women, six men; mean age 34 years, range 23 to 50 years) took part in the study after informed consent had been given. The largest dose of inhaled PGF2a which had no effect on the airways was determined for each subject and subsequently used as premedication during the construction of an inhalation dose-response curve to histamine.
Drugs were administered via a Wright's nebuliser, 571 driven by compressed air at 20 lbs/sq in and a flow of 10 There was no significant difference between baseline values of sGaw on the two occasions. Histamine responsiveness varied considerably between subjects and had no relationship to individual sensitivity to PGF2a. Four subjects tolerated the full six doses up to the 25 mg/ml solution; the studies were terminated because of chest tightness in three subjects after the 15 mg/ml solution, in one subject after the 20 mg/ml solution and in one after the 10 mg/ml solution. The challenges were continued to the same dose on both occasions in all subjects.
Analysis of the mean differences per dose between the curves indicated a significant shift to the left (p<0-001) after PGF2a premedication. Differences were present (p <0-005) after PGF2a at all doses of histamine up to the 20 mg/ml solution.
The values for D 20 % were significantly decreased after PGF2a (p < 0-0015) but there was no significant difference between the slopes of the regression lines. These results are illustrated in the figure where the dose-response regression lines between 20 
Discussion
The increased responsiveness of airway smooth muscle to bronchoconstrictor agents that occurs in asthmatic patients is characterised by both a smaller dose of agonist required to cause a response (sensitivity) and a steeper slope of the dose-response curve (reactivity) compared with normal subjects.'5 Increased bronchial responsiveness to histamine and methacholine can also be induced in normal subjects after a viral respiratory tract infection,3 influenza vaccination,4 5 or after ozone exposure6 but in these situations bronchial sensitivity is increased predominantly rather than reactivity.
Many of the circumstances such as allergen exposure, local trauma, and infection in the bronchial tree which lead to bronchial hyper-responsiveness are also those in which prostaglandins are generated in the lungs. 16 In this study we have shown that small doses of PGF2a insufficient themselves to alter airway calibre demonstrably do potentiate the bronchoconstrictor effect of inhaled histamine and shift the dose-response curve in a parallel fashion to the left indicating that it is bronchial sensitivity which is affected rather than reactivity. There is some evidence in support of each of these potential sites of action. Nadel'9 has suggested that bronchial epithelial damage and inflammation results in sensitisation of epithelial irritant receptors and that this is the underlying mechanism in all conditions of bronchial hyper-responsiveness. Pros 
